Showing 1 - 18 results of 18 for search 'Diamant Thaçi', query time: 0.03s Refine Results
  1. 1
    Corticosteroid-induced skin damage improved with pimecrolimus cream 1% treatment: a 1-year study in adults with mild to moderate atopic dermatitis

    Corticosteroid-induced skin damage improved with pimecrolimus cream 1% treatment: a 1-year study in adults with mild to moderate atopic dermatitis by Diamant Thaçi, Matthias Bräutigam, Thomas Luger

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Entzündungsmedizin: Optimierte intersektorale Zusammenarbeit als ein Schlüsselfaktor

    Entzündungsmedizin: Optimierte intersektorale Zusammenarbeit als ein Schlüsselfaktor by Priv.-Doz. Dr. med. Jürgen Rech, Prof. Dr. med. Diamant Thaçi

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis

    Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis by David A. De Luca, Cristian Papara, Tomasz Hawro, Diamant Thaçi, Sascha Ständer

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network

    Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network by Henner Zirpel, Ralf J. Ludwig, Henning Olbrich, Khalaf Kridin, Sascha Ständer, Diamant Thaçi

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)

    Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III... by Diamant Thaçi, Sascha Gerdes, Hendrik Schulze-Koops, Yannick Allanore, Arthur Kavanaugh, Charlotte Both, Sreekanth Gattu, Sohaib Hachaichi, Marco Matucci-Cerinic

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasisResearch in context

    Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasisResearch in context by Khalaf Kridin, Katja Bieber, Artem Vorobyev, Eva Lotta Moderegger, Henning Olbrich, Marlene A. Ludwig, Bernard Gershater, Gema Hernandez, Henner Zirpel, Diamant Thaci, Ralf J. Ludwig

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions

    Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions by Kenneth B. Gordon, Yayoi Tada, Milan J. Anadkat, Siew Eng Choon, Boni Elewski, Jonathan N. Barker, Arash Mostaghimi, Kilian Eyerich, Ming Tang, Thomas Haeufel, Christian Thoma, Diamant Thaçi

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions

    Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions by Kenneth B. Gordon, Yayoi Tada, Milan J. Anadkat, Siew Eng Choon, Boni Elewski, Jonathan N. Barker, Arash Mostaghimi, Kilian Eyerich, Ming Tang, Thomas Haeufel, Christian Thoma, Diamant Thaçi

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

    Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational... by Diamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Charles W. Lynde, Ahmed M. Soliman, Hongwei Wang, Christian Kaufmann, Doug G. Ashley, Tshepiso Madihlaba, Simone Rubant, Kim A. Papp

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms

    Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms by Joseph F. Merola, Philip J. Mease, April W. Armstrong, Vibeke Strand, Thomas Lehman, Stefan Varga, Jiyoon C. Choi, Brandon Becker, Yichen Zhong, Matthew J. Colombo, Diamant Thaçi, Androniki Bili, Alice B. Gottlieb

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

    Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 ... by Diamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Charles W. Lynde, Ahmed M. Soliman, Hongwei Wang, Christian Kaufmann, Doug G. Ashley, Tshepiso Madihlaba, Simone Rubant, Kim A. Papp

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study

    Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Stud... by Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, Michael Bukhalo, Neil J. Korman, Yu-Huei Huang, Georgios Kokolakis, Andreas Pinter, Nadia Ibrahim, Yanbing Zheng, Leonidas Drogaris, Vassilis Stakias, Ahmed M. Soliman, Simone Rubant, Diamant Thaçi

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study

    Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm... by Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, Michael Bukhalo, Neil J. Korman, Yu-Huei Huang, Georgios Kokolakis, Andreas Pinter, Nadia Ibrahim, Yanbing Zheng, Leonidas Drogaris, Vassilis Stakias, Ahmed M. Soliman, Simone Rubant, Diamant Thaçi

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

    Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials by Neil J. Korman, Richard B. Warren, Jerry Bagel, April W. Armstrong, Melinda Gooderham, Bruce Strober, Diamant Thaçi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M. Kisa, Subhashis Banerjee, Andrew Blauvelt

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)

    Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin) by Emma Guttman-Yassky, Stephan Weidinger, Eric L. Simpson, Melinda Gooderham, Alan D. Irvine, Lynda Spelman, Jonathan I. Silverberg, Hany ElMaraghy, Louise DeLuca-Carter, Maria Lucia Buziqui Piruzeli, Chaoran Hu, Fan Emily Yang, Evangeline Pierce, Laia Bardolet, Diamant Thaçi

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases

    Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases by Sadegh Mousavi, Katja Bieber, Henner Zirpel, Artem Vorobyev, Henning Olbrich, Cristian Papara, Cristian Papara, David A. De Luca, David A. De Luca, Diamant Thaci, Enno Schmidt, Gabriele Riemekasten, Peter Lamprecht, Matthias Laudes, Khalaf Kridin, Khalaf Kridin, Khalaf Kridin, Ralf J. Ludwig, Ralf J. Ludwig

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX

    A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX by Ralf J. Ludwig, Ralf J. Ludwig, Ralf J. Ludwig, Matthew Anson, Matthew Anson, Henner Zirpel, Diamant Thaci, Henning Olbrich, Katja Bieber, Khalaf Kridin, Khalaf Kridin, Khalaf Kridin, Astrid Dempfle, Philip Curman, Philip Curman, Philip Curman, Philip Curman, Sizheng S. Zhao, Uazman Alam, Uazman Alam, Uazman Alam

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Meeting Report on “10th Anniversary Symposium on Inflammatory Skin Disease”

    Meeting Report on “10th Anniversary Symposium on Inflammatory Skin Disease” by Shirin Emtenani, John F. Baines, Katja Bieber, Evelyn Gaffal, Stephanie Goletz, Gema Hernández, Misa Hirose, Markus Hoffmann, Pascal Joly, Henriette Kirchner, Jörg Köhl, Sripriya Murthy, Sabrina Patzelt, Frank Petersen, Manuela Pigors, Gabriela Riemekasten, Leon F. Schmidt-Jiménez, Tanya Sezin, Malte Spielmann, Diamant Thaçi, Nina van Beek, Jens Waschke, Ralf J. Ludwig, Enno Schmidt

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: